Aspire Biopharma Holdings Statistics
Total Valuation
ASBP has a market cap or net worth of $27.91 million. The enterprise value is $30.61 million.
Important Dates
The next estimated earnings date is Saturday, May 24, 2025, before market open.
Earnings Date | May 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ASBP has 46.52 million shares outstanding.
Current Share Class | 46.52M |
Shares Outstanding | 46.52M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 27.60% |
Owned by Institutions (%) | 3.61% |
Float | 30.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | -37.14 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19
Current Ratio | 0.19 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 80.67% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ASBP has paid $1,494 in taxes.
Income Tax | 1,494 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.55% in the last 52 weeks. The beta is 0.37, so ASBP's price volatility has been lower than the market average.
Beta (5Y) | 0.37 |
52-Week Price Change | -94.55% |
50-Day Moving Average | 5.67 |
200-Day Moving Average | 10.03 |
Relative Strength Index (RSI) | 21.23 |
Average Volume (20 Days) | 1,127,134 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -646,663 |
Pretax Income | n/a |
Net Income | -648,157 |
EBITDA | n/a |
EBIT | -646,663 |
Earnings Per Share (EPS) | -$0.00 |
Full Income Statement Balance Sheet
The company has $16,541 in cash and $853,113 in debt, giving a net cash position of -$836,572 or -$0.02 per share.
Cash & Cash Equivalents | 16,541 |
Total Debt | 853,113 |
Net Cash | -836,572 |
Net Cash Per Share | -$0.02 |
Equity (Book Value) | -801,588 |
Book Value Per Share | -0.00 |
Working Capital | -801,588 |
Full Balance Sheet Cash Flow
Operating Cash Flow | -403,451 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |